Abstract:Adipogenesis has emerged as a new therapeutic target for regulating metabolism and achieving anti-inflammatory and anti-atherosclerotic effects via the release of adiponectin. However, at present, the effects and mechanism of action of dipeptidyl peptidase 4 (DPP4) stimulation on adiponectin production and adipogenesis have not been clarified. Here, we investigated the effects of DPP4 stimulation with monocyte chemoattractant protein-1 (MCP-1) on platelet-derived growth factor receptor alpha (PDGFRα) expression in adipose tissue and blood adiponectin levels. Stromal vascular fractions (SVFs) purified from human subcutaneous adipose tissue and inguinal adipose tissue of obese and diabetic (Leprdb/db) mice were treated with 50 ng of MCP-1 and plasma from control (Lepr+/+) mice supplemented with 10 ng or 50 ng of MCP-1. Treatment of SVFs from human subcutaneous adipose tissues with 50 ng of MCP-1 significantly increased AdipoQ, DPP4, peroxisome proliferator-activated receptor gamma (PPARγ), fatty-acid-binding protein (FABP4), and SERBF1 mRNA expression. MCP-1-supplemented plasma increased adiponectin, CCAAT-Enhancer-binding protein alpha (C/EBPα), DPP4, IL-33, and PDGFRα mRNA expression and adiponectin and DPP4 protein expression, while decreasing the expression of IL-10 mRNA in SVFs compared with the levels in the plasma treatment group. MCP-1-supplemented plasma was shown to increase PPARγ, PPARγ2, adiponectin, DPP4, and FABP4 and decrease IL-10 mRNA expression in PDGFRα cells from adipose tissue. Meanwhile, MCP-1-supplemented plasma increased MCP-1, PDGFRα, TNFα, adiponectin, and IL-1β and decreased IL-10 and FOXP3 mRNA expression in DPP4 cells. Moreover, the injection of MCP-1-supplemented plasma into adipose tissue increased the proportion of DPP4+ cells among PDGFRα+ cells from adipose tissue and plasma adiponectin levels of Leprdb/db mice compared with the levels in the plasma injection group. Our results demonstrate that DPP4+ cells are important adipose progenitor cells. Stimulation of DPP4 with MCP-1 increases adipogenesis-related gene expression and the population of DPP4+ cells among PDGFRα+ cells in SVFs and blood adiponectin levels. DPP4 stimulation could be a novel therapy to increase local adipogenesis and systemic adiponectin levels.

DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.

1705-P: Adipocyte Specific Ablation of P2Y14R Improves Glucose Metabolism in Mice with Diet-Induced Obesity

Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression

Dysregulation of DPP4 is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes under Insulin Resistance Status and Liraglutide Intervention.

Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis

Dmso_a_229838 2635..2644

Mice Lacking Dipeptidyl Peptidase IV Are Protected Against Obesity and Insulin Resistance

Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet–Fed Mice

Atip, in Hematopoietic Cells Improved Glucose Intolerance in Type 2 Diabetic Mice

High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes

Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice

DPP-4 Inhibitor Sitagliptin Improves Cardiac Function and Glucose Homeostasis and Ameliorates Β-Cell Dysfunction Together with Reducing S6K1 Activation and IRS-1 and IRS-2 Degradation in Obesity Female Mice

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance

1024 ANGIOTENSION II TYPE 2 RECEPTOR-INTERACTING PROTEIN, ATIP, IN HEMATOPOIETIC CELLS IMPROVED GLUCOSE INTOLERANCE IN TYPE 2 DIABETIC MICE

A Role for DPP4 Expression via Oxidized LDL/TLR4/TRIF/CD36 Pathways in Human Obesity and Atherosclerosis

DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment

Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells

Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity associated type 2 diabetes